RE:RE:RE:Under promise and I have a record of calling out management harshly- for not delivering on enrollment numbers and for not being transparent.
They cleared up a lot of the transparency issues for me on the 10/30 conference call. I did not see the hedge on any questions, in fact I heard them address tough questions that weren't asked but were raised on this bullboard.
Their answers were logical and it buys them time with me to show enrollment results and deliver.
I also belive there is a big near term catalyst- when they announce DaVita as a DIMI trial partner and that announcement will have to happen before that trial starts- so Q1.
If solid enrollment and a partnership with Toray, Baxter and DaVita doesn't start to turn the SP tide... well, up is down- and I imagine it will be a more frustrating ride until we get closer to final trial results.